Antibody-Mediated Inflammatory Central Nervous System Disorders: From Diagnosis to Management

Dear Colleagues,

Antibody-mediated inflammatory central nervous system disorders are an expanding spectrum of neurologic diseases caused by antibody-mediated inflammation, which can generally be divided into antibody-mediated CNS demyelinating syndromes and antibody-mediated encephalitis. Commonly, the former includes those known antibodies-mediated CNS disorders, such as neuromyelitis optica spectrum disorder (NMOSD), MOG antibody-associated demyelination, and autoimmune glial fibrillary acidic protein astrocytopathy. The latter is due to a variety of neuronal antibodies against the N-methyl, d-aspartate receptor (NMDAR), leucine-rich glioma-inactivated 1 protein (LGI1), amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors, glutamic acid decarboxylase 65 (GAD65), glycine receptors, GABA receptors, etc. This Special Issue aims to investigate the known antibodies and associated diseases and discuss the diagnosis and management of antibody-mediated inflammatory CNS disorders to provide potential for reversibility with early initiation of treatment. Clinical or basic research articles, review articles, and case reports will be accepted.

Prof. Dr. Mei-Ping Ding
Dr. Dai-Shi Tian
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the Special Issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Brain Sciences is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.